Protalix Biotherapeutics Inc Free Cash Flow Generation Index

Latest as of December 2025: 1.61x

Protalix Biotherapeutics Inc free cash flow generation index. Protalix Biotherapeutics Inc (PLX) has a Free Cash Flow Generation Index of 1.61x as of December 2025. Free cash flow of $3.27 Million represents 2% of operating cash flow ($2.03 Million).

FCF Generation Index

1.61x
Free Cash Flow / Operating CF

Free Cash Flow

$3.27 Million
USD

Operating Cash Flow

$2.03 Million
USD

Capital Expenditures

$1.24 Million
USD

Free Cash Flow Generation Index of Protalix Biotherapeutics Inc (2009–2024)

Free cash flow generation index of Protalix Biotherapeutics Inc from 2009 to 2024. Historical FCF Generation Index trend for Protalix Biotherapeutics Inc across 3 annual periods. See how financially flexible is Protalix Biotherapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Protalix Biotherapeutics Inc Free Cash Flow Generation Index by Year (2009–2024)

Protalix Biotherapeutics Inc free cash flow generation index by year from 2009 to 2024. Year-by-year Free Cash Flow Generation Index for Protalix Biotherapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Protalix Biotherapeutics Inc generate cash.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.85x $7.39 Million $8.67 Million $1.28 Million ▲ +137.8%
2012 -2.26x $-1.43 Million $635.00K $2.07 Million ▼ -362.2%
2009 0.86x $38.26 Million $44.45 Million $6.20 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).